Skin aging as a 10-factor network

Skin aging as a 10-factor network

Skin aging is a network, not a list

A map of the biology behind skin longevity: ten interconnected factors, three layers, and the circuits that make decline self-reinforcing.

Key points

  • Aging is a loss of fidelity in renewal, not an end to it. The body keeps rebuilding itself. With age, it rebuilds less accurately.
  • Published hallmark frameworks classify skin aging by cause. We regroup the same mechanisms by where they can be addressed, and add the structural properties of skin that cellular frameworks leave out.
  • The result is ten factors in three layers: molecular stress load, cellular health, and tissue structure. The exposome acts across all ten.
  • The factors are coupled. Experiments that perturb one move the others, and in four places the connections close into circuits. That is why decline accelerates.
  • The same circuits can run in reverse. Aged fibroblasts resume collagen synthesis when their matrix is restored. That is the case for addressing the system, not a single pathway.

Renewal that loses fidelity

Nothing in the body is permanent. Cells divide and are replaced, proteins are broken down and rebuilt, damaged organelles are cleared and remade. Over a decade, the body is largely rebuilt from the same instructions.

What changes with age is not that this rebuilding stops. It becomes less faithful. A young body rebuilds itself into a young body. An old body, running the same process from the same blueprint, rebuilds itself into an old one.

Aging, described biologically, is that loss of fidelity. Damage accumulates faster than it is cleared. The signals that direct repair grow noisier. The machinery that carries out renewal is degraded by the conditions it works in. Each cycle of rebuilding starts from a slightly worse template than the last.

The Hallmarks of Aging are the reference framework longevity science uses to name the processes behind that drift: nine when first proposed [1], twelve a decade later with the addition of disabled macroautophagy, chronic inflammation, and dysbiosis [2]. They also mark where the drift might be corrected. Renewal is already happening continuously. The objective is not to start it, but to restore its accuracy.

Why skin is different

Skin runs on the same biology as every other organ, with two differences that matter. The first is that its condition is visible. Drift in a liver or an artery is inferred from markers. In skin, it is legible on the surface.

The second is that skin renews on two very different clocks. Stratum corneum transit takes about 20 days in young adults and lengthens by more than 10 days in older ones [3]. Dermal collagen has an estimated half-life of about 15 years [4].

Skin is therefore the organ where drift shows earliest, and where restored fidelity should show soonest at the surface. It is also where the structural consequences of drift, once embedded in the dermis, take longest to clear.

Why we built an operational framework

Several groups have carried the hallmarks into dermatology. Jin and colleagues propose seven hallmarks of skin aging, grouped as primary causes of damage, antagonistic responses to it, and integrative culprits of the phenotype [5]. Furman and colleagues review how the hallmarks manifest in skin, and how skin aging and systemic aging influence each other in both directions [6].

These frameworks classify mechanisms by cause or category. None is organized around what can be intervened on. And a framework pitched at the level of the cell has no natural place for the organ-level structural processes that dominate visible skin aging: barrier lipid depletion, matrix cross-linking, loss of water-binding capacity. These are consequences of cellular decline, and drivers of it.

Our framework is an operational layer, not a competing taxonomy. It regroups the published mechanisms by how each can be addressed, and it adds the structural properties of skin that cellular frameworks are not built around.

Ten factors, three layers

The framework yields ten interconnected factors of skin aging, grouped in three layers. The exposome acts across all ten.

Layer 1. Molecular stress load: (1) oxidative stress, (2) glycation and carbonyl stress, (3) senescent cell burden and the SASP, (4) chronic low-grade inflammation.

Layer 2. Cellular health: (5) bioenergetic decline, (6) proteostatic failure, (7) genomic maintenance decline.

Layer 3. Tissue structure: (8) matrix collapse, (9) hydration collapse, (10) barrier failure.

Load overwhelms the machinery, the machinery fails to maintain structure, and damaged structure feeds back into both.

Reading it as a network

These factors are analytically distinct but biologically inseparable. The evidence for their coupling comes from experiments in which one factor was perturbed and another moved:

  • Reactive oxygen species generate the mitochondrial DNA deletion characteristic of photoaged skin [7, 8]. Partial loss of mitochondrial DNA in dermal fibroblasts is enough to raise MMP-1 and lower type I collagen, through mitochondria-derived oxidative stress [9].
  • Persistent DNA damage signaling is what switches on the inflammatory secretome of senescent cells [10].
  • Senescent human fibroblasts overproduce collagenase and underproduce its inhibitor [11, 12].
  • Inflammatory cytokines induce collagenase in dermal fibroblasts [13, 14].
  • Fragmented collagen, the end product of that cascade, raises oxidant levels in the fibroblasts that sit on it and drives further MMP-1 expression. The loop closes from structure back to load [15].

Skin aging is therefore not ten independent defects. It is a coupled system in which deterioration at one level propagates through the others, and what it progressively loses is regenerative capacity itself.

Young skin rebuilds continuously. Fibroblasts synthesize new matrix, the barrier renews, damaged proteins and organelles are cleared and replaced, energy supply and genomic integrity are maintained. Skin does not age because it runs out of raw materials. It ages because the machinery that makes them, and the signals that instruct that machinery, lose fidelity.

Layer 1: molecular stress load

The first layer is the load placed on the system: molecular damage, modified macromolecules, dysfunctional cells, and inflammatory signals that must be neutralized, repaired, cleared, or replaced. With age this load rises while the machinery that resolves it (Layer 2) becomes less efficient, and the structures it damages (Layer 3) begin to generate load of their own.

1. Oxidative stress

Reactive oxygen species arise continuously from mitochondrial respiration. Ultraviolet, visible, and infrared radiation and airborne pollutants add pressure from outside [16, 17]. Against this, the skin's antioxidant reserve thins. In human skin measured in vivo, the major non-enzymatic antioxidants of the epidermis and the antioxidant enzymes of the dermis decline in both naturally aged and photoaged skin, some to roughly 60% of young levels [18]. Photoaged dermis accumulates oxidatively modified proteins [19].

Oxidative stress does more than damage proteins, lipids, and DNA directly. It changes the signaling environment skin cells work in. Repeated oxidative cues activate AP-1 and NF-κB-dependent transcription and tip TGF-β/SMAD signaling toward breakdown, by downregulating the TGF-β type II receptor [20] and by inducing the pathway's own inhibitor, Smad7, through AP-1 [21]. The result is more MMP-1, MMP-3, and MMP-9, suppressed procollagen synthesis, and progressive disruption of matrix homeostasis [22, 23]. The same mechanisms run in chronological aging, at lower intensity, in photoprotected skin [24, 25].

In the network. Oxidative stress is the most connected factor. It is fed by dysfunctional mitochondria (5), by the exposome, and by fragmented matrix (8), which raises oxidant levels inside the fibroblasts that rest on it [15]. It feeds glycoxidation (2), mitochondrial DNA damage (5), nuclear DNA damage (7), and, through AP-1 and the metalloproteinases, matrix collapse (8).

2. Glycation and carbonyl stress

Reactive dicarbonyls arise continuously from metabolism: methylglyoxal from glycolytic intermediates, ketone-body metabolism, and threonine catabolism, and glyoxal from lipid peroxidation and glycation [26]. They react with lysine and arginine residues to form advanced glycation end products, or AGEs [26, 27].

The major methylglyoxal-derived adducts form without any oxidative step [27]. Other AGEs, the glycoxidation products such as carboxymethyllysine (CML) and the cross-link pentosidine, do require oxidation [28]. Carbonyl stress is therefore its own axis of damage, only partly coupled to oxidative stress.

In human skin collagen, CML, pentosidine, and collagen-linked fluorescence rise roughly five-fold between the ages of 20 and 85 [29], increasing linearly with age [4]. Dermal CML becomes detectable after about age 35 and then rises rapidly, with sun exposure adding to it [30].

Slow turnover is why it accumulates. With a collagen half-life near 15 years, a modification that would be cleared from a fast-turnover protein persists and becomes part of the tissue's architecture [4]. AGE cross-linking stiffens collagen networks, as shown in human cartilage [31], and heavily cross-linked collagen resists enzymatic remodeling [32, 33]. Glycated matrix is not only damaged. It is harder to replace.

AGE-modified proteins also engage the receptor RAGE, which fibroblasts, keratinocytes, and dermal dendrocytes express in human skin, and which AGEs and TNF-α upregulate [34]. In keratinocytes, AGE–RAGE engagement activates NF-κB and induces MMP-9 [35], sustaining inflammatory signaling independent of ultraviolet exposure [36]. In dermal fibroblasts the picture is less settled: CML-modified protein raised procollagen rather than metalloproteinase expression [34].

In the network. Glycation is fed by oxidative stress (1) and by inflammation (4), which upregulates RAGE. It feeds matrix collapse (8) directly, and it reaches back into cell behavior. In reconstructed human skin, a glycated collagen matrix on its own is enough to activate fibroblasts, raise MMP-1, MMP-2, and MMP-9, thicken the basement membrane, and alter epidermal integrin expression in a pattern that closely resembles aged skin [37]. Structure that has been chemically modified changes the behavior of the cells charged with maintaining it.

3. Senescent cell burden and the SASP

Senescent keratinocytes and fibroblasts accumulate and persist in human skin with age. This was first shown with senescence-associated β-galactosidase across donors of different ages [38], and later with p16INK4A, whose positive cells rise with chronological age [39] and track biological age [40]. Resident immune cells in skin may also become senescent [41].

Senescence is protective when damaged cells must be stopped from dividing. Its consequences change when those cells are not cleared. Senescent cells stay metabolically active and secrete a senescence-associated secretory phenotype (SASP) rich in IL-6, IL-8, and matrix metalloproteinases [42, 43]. Senescent human skin fibroblasts show a more than 20-fold rise in collagenase activity while producing relatively little of its inhibitor, TIMP [12]. Aged fibroblasts raise collagenase and stromelysin transcripts while lowering TIMP-1 [11]. Fibroblasts from intrinsically aged skin secrete a protein set whose overlap with the classical SASP is exactly matrix degradation and pro-inflammatory signaling [44].

The damage spreads. Senescent cells transmit senescence to their neighbors through secreted factors and through direct cell contact [45, 46], turning a local cellular event into a tissue-level one [47].

In the network. Senescence is fed by persistent DNA damage (7), the trigger for the inflammatory arm of the SASP [10]; by mitochondrial dysfunction (5), which induces a senescence program with its own secretory profile [48, 49]; and by failing autophagy (6), whose impairment alone pushes primary human fibroblasts into premature senescence [50]. It feeds inflammation (4) and, through the metalloproteinases, matrix collapse (8).

4. Chronic low-grade inflammation ("inflammaging")

Inflammaging, the chronic, sterile, low-grade inflammatory state that develops with age, was first described as a rise in pro-inflammatory tone alongside a declining capacity to cope with stress [51]. It is sustained by cell debris and misplaced self-molecules sensed by innate immune receptors [52, 53]. In skin it is closely tied to senescence and to structural decline [54]. It also amplifies oxidative stress: activated phagocytes release reactive oxygen and nitrogen species and proteases that activate the metalloproteinases [55].

What changes is regulation, not only level. Langerhans cell density in the epidermis falls with age, and the cells that remain migrate less readily in response to TNF-α [56, 57]. Meanwhile, danger signals from damaged proteins, oxidized lipids, senescent cells, and AGE-modified macromolecules sustain innate signaling. Weaker surveillance and resolution coexist with persistent low-grade signaling. Wound healing, which depends on precisely timed inflammation, is delayed in healthy older adults [58, 59], and impaired cytokine signaling is among the proposed causes [60].

In the network. Inflammation is both an output of accumulated damage and a source of new damage. It is fed by the SASP (3), by AGE–RAGE signaling (2), and by a compromised barrier (10). It feeds matrix collapse directly: IL-1 and TNF-α each induce collagenase in human dermal fibroblasts [13, 14], and IL-1 raises collagenase and stromelysin in aged fibroblasts [11]. It upregulates RAGE (2) [34], reinforces oxidative stress (1) [55], spreads senescence to neighboring cells (3) through inflammasome and IL-1 signaling [45], and adds damaged proteins to the clearance burden of Layer 2.

Layer 2: cellular health

The second layer is the machinery that maintains the tissue. Cells need energy to synthesize new proteins and lipids, systems to find and remove damaged components, and genomic maintenance that preserves the instructions replacement material is made from.

Aging creates a dual problem: the load rises while the machinery available to process it declines. The three factors in this layer are also tightly coupled to each other. Mitochondrial and proteasomal function are co-regulated in human dermal fibroblasts [61], and NAD⁺ is the shared currency of energy metabolism and DNA repair [62]. Decline in one is rarely isolated.

5. Bioenergetic decline

Mitochondria sit at the intersection of energy production, redox signaling, stress responses, and repair. In human skin fibroblasts, the efficiency of oxidative phosphorylation declines with donor age, and mitochondrial protein synthesis and respiration rate fall markedly after age 40 [63]. Fibroblasts from aged donors show lower mitochondrial membrane potential and higher ROS production [61]. Quality control through mitophagy and biogenesis becomes less efficient, and damaged mitochondria accumulate [64, 65]. In skin specifically, ultraviolet A generates the 4,977-base-pair "common deletion" of mitochondrial DNA through singlet oxygen [7]. Repeated exposure induces it in normal human skin, where it persists and keeps accumulating for months after exposure stops [8].

The consequence is not simply less ATP. Altered mitochondrial function changes redox tone, metabolite supply, and calcium signaling, and the energy available for protein synthesis, lipid production, DNA repair, and matrix remodeling [65]. Damaged mitochondria also signal outward: partial depletion of mitochondrial DNA in skin fibroblasts raises MMP-1 and lowers type I collagen in a pattern reminiscent of photoaged skin [9, 66].

NAD⁺ is the second half of this infrastructure. It is the sole substrate for the DNA-repair enzyme PARP and for the sirtuins [67]. In human skin, NAD⁺ declines with age in both sexes, and rising PARP activity, inversely correlated with NAD⁺, is evident in men [62]. The interpretation these data support is that accumulating DNA damage activates PARP, which draws down NAD⁺ [62]. Consistent with this, inhibiting PARP-1 in mice raises NAD⁺ content and mitochondrial metabolism [68].

In the network. Bioenergetic decline is fed by oxidative stress (1), by exposome inputs that act directly on mitochondria, infrared-A radiation in particular [69], and by the NAD⁺ demand of DNA repair (7). It feeds oxidative stress in return (1), senescence through its own distinct program (3) [49], proteostatic failure through the co-regulation of mitochondrial and proteasomal function (6) [61], and, through retrograde signaling to MMP-1 and collagen, matrix collapse (8). It is the factor that connects accumulated damage most directly to declining regenerative capacity.

6. Proteostatic failure

Proteostasis, the maintenance of a functional proteome through synthesis, folding, and clearance, erodes with age across tissues [70, 71]. In human epidermis the evidence is direct. Cells from older donors carry more oxidized, glycated, and lipid-peroxidation-modified proteins, alongside decreased proteasome activity and content [72] and structural alterations in the proteasome itself [73].

Autophagy, the pathway that clears larger damaged components including whole organelles, is compromised too. Dermal fibroblasts from older donors accumulate autophagosomes in a pattern consistent with impaired flux, and blocking lysosomal degradation in young fibroblasts alters their output of procollagen, hyaluronan, and elastin and breaks down collagen fibrils [74, 75].

Renewal requires more than synthesis. Damaged proteins and organelles must first be identified, dismantled, and recycled. When turnover slows, defective material stays in the system longer and adds stress to the machinery responsible for maintaining it.

In the network. Proteostatic failure is fed by oxidative and carbonyl stress (1, 2), which generate the modified proteins that must be cleared, and by mitochondrial dysfunction (5). In human dermal fibroblasts, inhibiting mitochondrial function reduces proteasome activity, and inhibiting the proteasome reduces mitochondrial function [61]. It feeds senescence (3): silencing autophagy genes is enough to induce premature senescence in primary human fibroblasts [50], and in aged mouse muscle stem cells, autophagy failure drives entry into senescence [76]. It feeds structure (8) through the altered matrix output of fibroblasts with impaired flux [75]. The result is a feed-forward loop: the need for clearance rises at the same time clearance capacity falls.

7. Genomic maintenance decline

Skin is continuously exposed to genomic stress from metabolism and environment. Reactive oxygen species generate oxidized bases such as 8-oxoguanine and strand breaks, and ultraviolet radiation introduces cyclobutane pyrimidine dimers and 6-4 photoproducts [77]. DNA damage affects most aspects of the aging phenotype and has been proposed as a unifying cause of aging [78].

Repair capacity declines with age. In cultured human skin fibroblasts, repair of thymine dimers and 6-4 photoproducts slows significantly with donor age, alongside reduced levels of the repair proteins themselves [79], and post-UV repair capacity falls by roughly 0.6% a year across the lifespan [80]. The cumulative result is visible in normal skin. Sun-exposed eyelid epidermis from four older donors carried two to six mutations per megabase per cell, a burden comparable to many cancers, arranged in thousands of competing clones [81].

In the network. Genomic maintenance sits upstream of several other factors. It is fed by oxidative stress (1) and the exposome. It feeds senescence (3): the DNA damage response is a principal route into senescence [82], and persistent, unresolved damage signaling, rather than transient damage, triggers the IL-6 and other inflammatory cytokines that characterize it [10]. It feeds bioenergetic decline (5), because PARP-dependent repair consumes NAD⁺ [62, 68]. Failure to preserve the blueprint constrains how faithfully skin cells can keep renewing the tissue over repeated cycles.

Layer 3: tissue structure

The third layer is the tissue the cellular machinery must maintain: the collagen- and elastin-rich dermal matrix, its hydrated glycosaminoglycan environment, and the lipid-rich epidermal barrier.

These structures are not passive endpoints. They regulate mechanical signaling, water balance, and cell behavior, and their deterioration feeds back into the systems responsible for rebuilding them. That feedback is why structure belongs inside the framework rather than at the end of it.

8. Matrix collapse

Dermal collagen declines with age through adult life [83]. Fibroblasts from aged donors make less type I procollagen and attach less well to the collagen around them, consistent with lower mechanical stimulation [25]. Photoexposed dermis adds accelerated breakdown. Seven metalloproteinases are elevated in photodamaged forearm skin without a compensating rise in their inhibitors [84], and disorganized, nonfunctional elastic material accumulates as solar elastosis [17, 85].

The core mechanism is a loop between cell and matrix. Fibroblasts sense the matrix through integrins, focal adhesions, and cytoskeletal tension. Fragmented collagen cannot support normal attachment or tension. Fibroblasts on it collapse, downregulate the TGF-β type II receptor, induce CCN1 and AP-1, and produce less collagen and more metalloproteinases, which fragment more collagen [86–88]. In three-dimensional lattices of fragmented collagen, the same cells show raised intracellular oxidant levels, and lowering that oxidant burden lowers their MMP-1 expression [15]. Matrix fragmentation and oxidative stress are directly coupled.

The loop runs in both directions. When structural support was restored in aged human skin in vivo, by injecting a cross-linked dermal filler, fibroblasts spread, upregulated the TGF-β type II receptor, and resumed type I collagen production [89]. Aged fibroblasts keep their capacity for activation. What they lack is a matrix that instructs them to use it.

In the network. Matrix collapse is fed by oxidative stress and AP-1 signaling (1), by glycation (2), by the SASP (3), by inflammatory cytokines (4), and by every Layer 2 factor through reduced synthesis and clearance. It feeds back into oxidative stress (1) [15] and into the fibroblast machinery itself through mechanosignaling. It is the cumulative product of altered synthesis, accelerated degradation, impaired maturation, biochemical modification, and a progressively less supportive mechanical environment.

9. Hydration collapse

Water in skin is not held passively. In the dermis, hyaluronan and other glycosaminoglycans form a hydrated environment that contributes to tissue volume, viscoelasticity, molecular transport, and the physical surroundings of fibroblasts. Half the body's hyaluronan is in skin, and it is the principal determinant of the skin's water content [90–92].

What changes with age is less the quantity of hyaluronan than its organization and integrity. Total hyaluronan in human skin does not fall appreciably with chronological age, but it becomes progressively more tissue-bound and harder to extract [92, 93]. Epidermal hyaluronan and dermal sulfated glycosaminoglycans do decline with intrinsic aging, and in the epidermis they track tissue water content [94]. In photoexposed skin, hyaluronan is more abundant but of lower molecular mass, with reduced expression of the synthase HAS1, increased hyaluronidase expression, and downregulated receptors [95]. Transiently hydrating the surface does not correct this.

Molecular size matters because hyaluronan is also a signal. High-molecular-mass hyaluronan reflects intact tissue. Small fragments act as danger signals that drive inflammatory gene expression through Toll-like receptors and CD44 [96, 97]. Reactive oxygen species degrade hyaluronan into exactly such fragments [98].

In the network. Hydration collapse is fed by oxidative stress (1), which fragments hyaluronan, and by declining fibroblast function (5, 6, 8), which reduces the capacity to maintain the glycosaminoglycan environment. It feeds inflammation (4) through fragment signaling, and matrix collapse (8), because the hydrated matrix is part of the environment fibroblasts work in.

10. Barrier failure

With age, epidermal renewal slows. Stratum corneum transit lengthens from about 20 days in young adults to more than 30 in older ones, reflecting reduced keratinocyte proliferation [3]. Stratum corneum lipid content declines [99]. In senile xerosis, filaggrin protein is reduced while its transcript is not, pointing to accelerated breakdown. Stratum corneum free amino acids are increased rather than depleted in that condition, so a simple loss of natural moisturizing factor should not be assumed [100].

The signature of the aged barrier is not, as often assumed, higher resting water loss. Baseline transepidermal water loss in aged skin is actually subnormal. What changes is resilience. The aged barrier is breached by far fewer insults and recovers far more slowly: about 15% recovery at 24 hours in adults over 80, against 50% in young adults [101, 102].

The stratum corneum is a metabolically maintained structure whose defensive functions are linked, so a failure in one impairs the others [103]. When its renewal becomes less efficient, everyday challenges such as low humidity and cold breach it more easily, water escapes, and irritants reach viable tissue [104].

In the network. Barrier failure is fed by slowed epidermal renewal, declining stratum corneum lipids, and the exposome. Its most important output is inflammation (4). Barrier perturbation triggers a cytokine cascade in the epidermis, shown in mice [105] and in human skin in vivo [106]. In mice, acute barrier disruption raises serum cytokine levels; aged mice show elevated cytokines in both skin and serum, and correcting epidermal function lowers the serum levels [107]. In a pilot study in chronically aged adults, 30 days of a topical emollient improved barrier function, normalized circulating IL-1β and IL-6, and substantially reduced TNF-α [108]. The outermost structural layer is wired directly to the inflammatory load beneath it, and through inflammation to matrix degradation (8).

The exposome: acting across all ten

The skin aging exposome is the totality of environmental exposure accumulated over a lifetime: solar radiation across the ultraviolet, visible, and infrared bands, air pollution, tobacco smoke, nutrition, climate, and psychological stress [109]. It adds no mechanism of its own. It accelerates the ten already described.

  • Ultraviolet. UVA reaches the viable epidermis and upper dermis, where endogenous chromophores act as photosensitizers and generate reactive oxygen species, including singlet oxygen [110]. Solar-simulated ultraviolet suppresses procollagen synthesis through c-Jun and induces the metalloproteinases [22, 23].
  • Visible light, which conventional sunscreens do not block, induces ROS, pro-inflammatory cytokines, and MMP-1 in human skin equivalents, and raises free-radical activity in human skin in vivo [111].
  • Infrared-A perturbs the mitochondrial electron transport chain in vitro and induces dermal MMP-1 in most exposed individuals in vivo [69].
  • Pollution and smoke. Airborne particulate exposure correlates with pigment spots and, less strongly, wrinkles in older women [112]. Tobacco smoke extract impairs collagen production and induces metalloproteinases through oxidative stress [113], and in a small cross-sectional study smoking multiplied the wrinkling risk of sun exposure [114].
  • Climate. Low humidity and cold reduce barrier function and make skin more reactive [104].

Repeated insults superimpose photoaging on intrinsic aging: coarse texture, dyspigmentation, elastic fiber degeneration. Yet even in photoprotected skin, the same network drives a slower but similar trajectory [24, 25]. The exposome is not an eleventh factor. It increases load, damages the machinery, and accelerates the degradation of structure.

Four circuits that make decline self-reinforcing

The three layers describe parts of one system. Molecular stress load is what the tissue must withstand and resolve. Cellular health is the machinery that resolves it. Tissue structure is what that machinery maintains. As load rises and the machinery declines, structure deteriorates, and damaged structure feeds back into both.

In four places, the connections close on themselves. A chain of damage runs from one factor through others and returns to amplify its own starting point. Where that happens, decline does not add up at a steady rate. It accelerates, because each pass around the circuit leaves the system less able to resist the next.

  1. The matrix loop (1, 4, 8). Oxidative stress and inflammation raise the metalloproteinases. The metalloproteinases fragment collagen. Fragmented collagen collapses fibroblasts and raises their oxidant output, and collapsed fibroblasts make less collagen and more metalloproteinases.
  2. The mitochondrial loop (1, 5, 7). Oxidative stress damages mitochondrial DNA. Damaged mitochondria produce more ROS and signal toward a catabolic, senescence-prone state. The NAD⁺ consumed in repairing DNA damage is unavailable for mitochondrial maintenance.
  3. The senescence loop (3 to 7). Persistent DNA damage, mitochondrial dysfunction, and failing autophagy each push cells into senescence. The senescent secretome spreads inflammation and senescence to neighboring cells and degrades matrix.
  4. The barrier loop (4, 10). A less resilient barrier admits more inflammatory signaling, and inflammation impairs the renewal that maintains the barrier.

What this means for intervention

Aging skin is not simply "oxidized." It is a system with reduced renewal capacity, altered mechanical signaling, impaired damage clearance, declining energetic and genomic maintenance, and accumulating protein modifications that resist removal.

These circuits are why no single factor can be addressed in isolation. Interrupting one link slows a loop. Leaving the others intact allows it to restart. Supplying raw material to a system in this state does little to correct the upstream biology, just as adding fuel does not repair a worn engine.

The same biology shows that the system is not inert. Fibroblasts in aged skin resume collagen synthesis when their structural environment is restored [89]. Repairing the barrier in aged adults lowers inflammatory markers in the blood [108]. Circuits that drive decline can be driven the other way.

Any rational intervention, topical or oral, has to account for this coupled biology rather than chase a single pathway. 

References

  1. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–1217. doi
  2. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186(2):243–278. doi
  3. Grove GL, Kligman AM. Age-associated changes in human epidermal cell renewal. J Gerontol. 1983;38(2):137–142. doi
  4. Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275(50):39027–39031. doi
  5. Jin S, Li K, Zong X, Eun S, Morimoto N, Guo S. Hallmarks of skin aging: update. Aging Dis. 2023;14(6):2167–2176. doi
  6. Furman D, Auwerx J, Bulteau AL, et al. Skin health and biological aging. Nat Aging. 2025;5(7):1195–1206. doi
  7. Berneburg M, Grether-Beck S, Kürten V, et al. Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem. 1999;274(22):15345–15349. doi
  8. Berneburg M, Plettenberg H, Medve-König K, et al. Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin. J Invest Dermatol. 2004;122(5):1277–1283. doi
  9. Schroeder P, Gremmel T, Berneburg M, Krutmann J. Partial depletion of mitochondrial DNA from human skin fibroblasts induces a gene expression profile reminiscent of photoaged skin. J Invest Dermatol. 2008;128(9):2297–2303. doi
  10. Rodier F, Coppé JP, Patil CK, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol. 2009;11(8):973–979. doi
  11. Millis AJ, Hoyle M, McCue HM, Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res. 1992;201(2):373–379. doi
  12. West MD, Pereira-Smith OM, Smith JR. Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. Exp Cell Res. 1989;184(1):138–147. doi
  13. Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 1985;162(6):2163–2168. doi
  14. Postlethwaite AE, Lachman LB, Mainardi CL, Kang AH. Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med. 1983;157(2):801–806. doi
  15. Fisher GJ, Quan T, Purohit T, et al. Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts in aged human skin. Am J Pathol. 2009;174(1):101–114. doi
  16. Rinnerthaler M, Bischof J, Streubel MK, Trost A, Richter K. Oxidative stress in aging human skin. Biomolecules. 2015;5(2):545–589. doi
  17. Wlaschek M, Tantcheva-Poór I, Naderi L, et al. Solar UV irradiation and dermal photoaging. J Photochem Photobiol B. 2001;63(1-3):41–51. doi
  18. Rhie G, Shin MH, Seo JY, et al. Aging- and photoaging-dependent changes of enzymic and nonenzymic antioxidants in the epidermis and dermis of human skin in vivo. J Invest Dermatol. 2001;117(5):1212–1217. doi
  19. Sander CS, Chang H, Salzmann S, et al. Photoaging is associated with protein oxidation in human skin in vivo. J Invest Dermatol. 2002;118(4):618–625. doi
  20. Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling. Am J Pathol. 2004;165(3):741–751. doi
  21. Quan T, He T, Voorhees JJ, Fisher GJ. Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts. J Biol Chem. 2005;280(9):8079–8085. doi
  22. Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997;337(20):1419–1428. doi
  23. Fisher GJ, Datta S, Wang Z, et al. c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest. 2000;106(5):663–670. doi
  24. Rittié L, Fisher GJ. UV-light-induced signal cascades and skin aging. Ageing Res Rev. 2002;1(4):705–720. doi
  25. Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006;168(6):1861–1868. doi
  26. Thornalley PJ. Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors. Chem Biol Interact. 1998;111-112:137–151. doi
  27. Rabbani N, Xue M, Thornalley PJ. Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments. Clin Sci (Lond). 2016;130(19):1677–1696. doi
  28. Fu MX, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes. 1994;43(5):676–683. doi
  29. Dyer DG, Dunn JA, Thorpe SR, et al. Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest. 1993;91(6):2463–2469. doi
  30. Jeanmaire C, Danoux L, Pauly G. Glycation during human dermal intrinsic and actinic ageing: an in vivo and in vitro model study. Br J Dermatol. 2001;145(1):10–18. doi
  31. Verzijl N, DeGroot J, Ben ZC, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 2002;46(1):114–123. doi
  32. Nowotny K, Grune T. Degradation of oxidized and glycoxidized collagen: role of collagen cross-linking. Arch Biochem Biophys. 2014;542:56–64. doi
  33. Panwar P, Butler GS, Jamroz A, et al. Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases. Matrix Biol. 2017;65:30–44. doi
  34. Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol. 2006;126(2):291–299. doi
  35. Zhu P, Ren M, Yang C, Hu YX, Ran JM, Yan L. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol. 2012;21(2):123–129. doi
  36. Gkogkolou P, Böhm M. Advanced glycation end products: key players in skin aging? Dermatoendocrinol. 2012;4(3):259–270. doi
  37. Pageon H, Bakala H, Monnier VM, Asselineau D. Collagen glycation triggers the formation of aged skin in vitro. Eur J Dermatol. 2007;17(1):12–20. doi
  38. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92(20):9363–9367. doi
  39. Ressler S, Bartkova J, Niederegger H, et al. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell. 2006;5(5):379–389. doi
  40. Waaijer MEC, Parish WE, Strongitharm BH, et al. The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell. 2012;11(4):722–725. doi
  41. He X, Gao X, Xie W. Research progress in skin aging and immunity. Int J Mol Sci. 2024;25(7):4101. doi
  42. Coppé JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6(12):2853–2868. doi
  43. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99–118. doi
  44. Waldera Lupa DM, Kalfalah F, Safferling K, et al. Characterization of skin aging-associated secreted proteins (SAASP) produced by dermal fibroblasts isolated from intrinsically aged human skin. J Invest Dermatol. 2015;135(8):1954–1968. doi
  45. Acosta JC, Banito A, Wuestefeld T, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978–990. doi
  46. Nelson G, Wordsworth J, Wang C, et al. A senescent cell bystander effect: senescence-induced senescence. Aging Cell. 2012;11(2):345–349. doi
  47. Wlaschek M, Maity P, Makrantonaki E, Scharffetter-Kochanek K. Connective tissue and fibroblast senescence in skin aging. J Invest Dermatol. 2021;141(4S):985–992. doi
  48. Correia-Melo C, Marques FDM, Anderson R, et al. Mitochondria are required for pro-ageing features of the senescent phenotype. EMBO J. 2016;35(7):724–742. doi
  49. Wiley CD, Velarde MC, Lecot P, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 2016;23(2):303–314. doi
  50. Kang HT, Lee KB, Kim SY, Choi HR, Park SC. Autophagy impairment induces premature senescence in primary human fibroblasts. PLoS One. 2011;6(8):e23367. doi
  51. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244–254. doi
  52. Feldman N, Rotter-Maskowitz A, Okun E. DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev. 2015;24(Pt A):29–39. doi
  53. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–590. doi
  54. Pilkington SM, Bulfone-Paus S, Griffiths CEM, Watson REB. Inflammaging and the skin. J Invest Dermatol. 2021;141(4S):1087–1095. doi
  55. Pillai S, Oresajo C, Hayward J. Ultraviolet radiation and skin aging: roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation, a review. Int J Cosmet Sci. 2005;27(1):17–34. doi
  56. Gilchrest BA, Murphy GF, Soter NA. Effect of chronologic aging and ultraviolet irradiation on Langerhans cells in human epidermis. J Invest Dermatol. 1982;79(2):85–88. doi
  57. Bhushan M, Cumberbatch M, Dearman RJ, Andrew SM, Kimber I, Griffiths CEM. Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br J Dermatol. 2002;146(1):32–40. doi
  58. Holt DR, Kirk SJ, Regan MC, Hurson M, Lindblad WJ, Barbul A. Effect of age on wound healing in healthy human beings. Surgery. 1992;112(2):293–297; discussion 297–298.
  59. Gosain A, DiPietro LA. Aging and wound healing. World J Surg. 2004;28(3):321–326. doi
  60. Ashcroft GS, Mills SJ, Ashworth JJ. Ageing and wound healing. Biogerontology. 2002;3(6):337–345. doi
  61. Kozieł R, Greussing R, Maier AB, Declercq L, Jansen-Dürr P. Functional interplay between mitochondrial and proteasome activity in skin aging. J Invest Dermatol. 2011;131(3):594–603. doi
  62. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. 2012;7(7):e42357. doi
  63. Greco M, Villani G, Mazzucchelli F, Bresolin N, Papa S, Attardi G. Marked aging-related decline in efficiency of oxidative phosphorylation in human skin fibroblasts. FASEB J. 2003;17(12):1706–1708. doi
  64. Markaki M, Palikaras K, Tavernarakis N. Novel insights into the anti-aging role of mitophagy. Int Rev Cell Mol Biol. 2018;340:169–208. doi
  65. Sun N, Youle RJ, Finkel T. The mitochondrial basis of aging. Mol Cell. 2016;61(5):654–666. doi
  66. Krutmann J, Schroeder P. Role of mitochondria in photoaging of human skin: the defective powerhouse model. J Investig Dermatol Symp Proc. 2009;14(1):44–49. doi
  67. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119–141. doi
  68. Bai P, Cantó C, Oudart H, et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011;13(4):461–468. doi
  69. Schroeder P, Lademann J, Darvin ME, et al. Infrared radiation-induced matrix metalloproteinase in human skin: implications for protection. J Invest Dermatol. 2008;128(10):2491–2497. doi
  70. Hipp MS, Kasturi P, Hartl FU. The proteostasis network and its decline in ageing. Nat Rev Mol Cell Biol. 2019;20(7):421–435. doi
  71. Labbadia J, Morimoto RI. The biology of proteostasis in aging and disease. Annu Rev Biochem. 2015;84:435–464. doi
  72. Petropoulos I, Conconi M, Wang X, et al. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci. 2000;55(5):B220–B227. doi
  73. Bulteau AL, Petropoulos I, Friguet B. Age-related alterations of proteasome structure and function in aging epidermis. Exp Gerontol. 2000;35(6-7):767–777. doi
  74. Eckhart L, Tschachler E, Gruber F. Autophagic control of skin aging. Front Cell Dev Biol. 2019;7:143. doi
  75. Tashiro K, Shishido M, Fujimoto K, et al. Age-related disruption of autophagy in dermal fibroblasts modulates extracellular matrix components. Biochem Biophys Res Commun. 2014;443(1):167–172. doi
  76. García-Prat L, Martínez-Vicente M, Perdiguero E, et al. Autophagy maintains stemness by preventing senescence. Nature. 2016;529(7584):37–42. doi
  77. Cadet J, Douki T. Formation of UV-induced DNA damage contributing to skin cancer development. Photochem Photobiol Sci. 2018;17(12):1816–1841. doi
  78. Schumacher B, Pothof J, Vijg J, Hoeijmakers JHJ. The central role of DNA damage in the ageing process. Nature. 2021;592(7856):695–703. doi
  79. Goukassian D, Gad F, Yaar M, Eller MS, Nehal US, Gilchrest BA. Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J. 2000;14(10):1325–1334. doi
  80. Moriwaki S, Ray S, Tarone RE, Kraemer KH, Grossman L. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat Res. 1996;364(2):117–123. doi
  81. Martincorena I, Roshan A, Gerstung M, et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348(6237):880–886. doi
  82. d’Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer. 2008;8(7):512–522. doi
  83. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93(6):639–643. doi
  84. Quan T, Little E, Quan H, Qin Z, Voorhees JJ, Fisher GJ. Elevated matrix metalloproteinases and collagen fragmentation in photodamaged human skin: impact of altered extracellular matrix microenvironment on dermal fibroblast function. J Invest Dermatol. 2013;133(5):1362–1366. doi
  85. Weihermann AC, Lorencini M, Brohem CA, de Carvalho CM. Elastin structure and its involvement in skin photoageing. Int J Cosmet Sci. 2017;39(3):241–247. doi
  86. Fisher GJ, Varani J, Voorhees JJ. Looking older: fibroblast collapse and therapeutic implications. Arch Dermatol. 2008;144(5):666–672. doi
  87. Fisher GJ, Wang B, Cui Y, et al. Skin aging from the perspective of dermal fibroblasts: the interplay between the adaptation to the extracellular matrix microenvironment and cell autonomous processes. J Cell Commun Signal. 2023;17(3):523–529. doi
  88. Quan T, Fisher GJ. Role of age-associated alterations of the dermal extracellular matrix microenvironment in human skin aging: a mini-review. Gerontology. 2015;61(5):427–434. doi
  89. Quan T, Wang F, Shao Y, et al. Enhancing structural support of the dermal microenvironment activates fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo. J Invest Dermatol. 2013;133(3):658–667. doi
  90. Lee DH, Oh JH, Chung JH. Glycosaminoglycan and proteoglycan in skin aging. J Dermatol Sci. 2016;83(3):174–181. doi
  91. Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol. 2012;4(3):253–258. doi
  92. Stern R, Maibach HI. Hyaluronan in skin: aspects of aging and its pharmacologic modulation. Clin Dermatol. 2008;26(2):106–122. doi
  93. Meyer LJ, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol. 1994;102(3):385–389. doi
  94. Oh JH, Kim YK, Jung JY, et al. Intrinsic aging- and photoaging-dependent level changes of glycosaminoglycans and their correlation with water content in human skin. J Dermatol Sci. 2011;62(3):192–201. doi
  95. Tzellos TG, Klagas I, Vahtsevanos K, et al. Extrinsic ageing in the human skin is associated with alterations in the expression of hyaluronic acid and its metabolizing enzymes. Exp Dermatol. 2009;18(12):1028–1035. doi
  96. Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev. 2011;91(1):221–264. doi
  97. Stern R, Asari AA, Sugahara KN. Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 2006;85(8):699–715. doi
  98. Šoltés L, Mendichi R, Kogan G, Schiller J, Stankovska M, Arnhold J. Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules. 2006;7(3):659–668. doi
  99. Rogers J, Harding C, Mayo A, Banks J, Rawlings A. Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res. 1996;288(12):765–770. doi
  100. Takahashi M, Tezuka T. The content of free amino acids in the stratum corneum is increased in senile xerosis. Arch Dermatol Res. 2004;295(10):448–452. doi
  101. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM. The aged epidermal permeability barrier: structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest. 1995;95(5):2281–2290. doi
  102. Wang Z, Man MQ, Li T, Elias PM, Mauro TM. Aging-associated alterations in epidermal function and their clinical significance. Aging (Albany NY). 2020;12(6):5551–5565. doi
  103. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183–200. doi
  104. Engebretsen KA, Johansen JD, Kezic S, Linneberg A, Thyssen JP. The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol. 2016;30(2):223–249. doi
  105. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest. 1992;90(2):482–487. doi
  106. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol. 1994;30(4):535–546. doi
  107. Hu L, Mauro TM, Dang E, et al. Epidermal dysfunction leads to an age-associated increase in levels of serum inflammatory cytokines. J Invest Dermatol. 2017;137(6):1277–1285. doi
  108. Ye L, Mauro TM, Dang E, et al. Topical applications of an emollient reduce circulating pro-inflammatory cytokine levels in chronically aged humans: a pilot clinical study. J Eur Acad Dermatol Venereol. 2019;33(11):2197–2201. doi
  109. Krutmann J, Bouloc A, Sore G, Bernard BA, Passeron T. The skin aging exposome. J Dermatol Sci. 2017;85(3):152–161. doi
  110. Wondrak GT, Jacobson MK, Jacobson EL. Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem Photobiol Sci. 2006;5(2):215–237. doi
  111. Liebel F, Kaur S, Ruvolo E, Kollias N, Southall MD. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. J Invest Dermatol. 2012;132(7):1901–1907. doi
  112. Vierkötter A, Schikowski T, Ranft U, et al. Airborne particle exposure and extrinsic skin aging. J Invest Dermatol. 2010;130(12):2719–2726. doi
  113. Morita A. Tobacco smoke causes premature skin aging. J Dermatol Sci. 2007;48(3):169–175. doi
  114. Kadunce DP, Burr R, Gress R, Kanner R, Lyon JL, Zone JJ. Cigarette smoking: risk factor for premature facial wrinkling. Ann Intern Med. 1991;114(10):840–844. doi
Back to blog